Statistics for Zomedica Pharmaceuticalsrp (id:169 ZOM)

Valuation metrics

Market cap

132.29M

Enterprise value

42.04M

Trailing P/E (ttm)

-3.60

Forward P/E

-14.59

PEG ratio

Price/Sales (ttm)

5.07

Price/Book (mrq)

0.55

Enterprise Value/Revenue

1.61

Enterprise Value/EBITDA

-1.43

Overview

Shares outstanding

979.95M

Float

961.51M

Shares short

51.14M

% Held by insiders

0.02%

% Held by institutions

0.08%

Average volume (10 days)

10.18M

Average volume (90 days)

Price summary

52-Week low

0.12

52-Week high

0.23

52-Week change

-34.13%

Beta

1.06

50-Day moving average

0.13

200-Day moving average

0.14

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-214.70%

Operating margin

-147.50%

Operational effectiveness

Return on assets

-9.29%

Return on equity

-23.92%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

17.32M

EBITDA

-29,393,000.00

Net income to common (ttm)

-55,986,000.00

Diluted EPS (ttm)

-0.07

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

79.51M

Total cash per share (mrq)

0.08

Total debt (mrq)

2.29M

Total Debt/Equity (mrq)

1.10

Current ratio (mrq)

1.14K%

Book value per share (mrq)

0.24

Cash flow

Cash flow statement

-22,351,000.00

Levered free cash flow (LFCF)

-23,166,750.00